Suppr超能文献

一种利用医院和药物数据库监测类风湿性关节炎患病率的新方法。

A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases.

作者信息

Koller-Smith Louise, Mehdi Ahmed, March Lyn, Tooth Leigh, Mishra Gita D, Thomas Ranjeny

机构信息

Frazer Institute, The University of Queensland, Translational Research Institute (TRI), Level 7, 37 Kent St, Woolloongabba, QLD, 4102, Australia.

Florance and Cope Professorial Department of Rheumatology, Royal North Shore Hospital and Kolling Institute and Sydney MSK Flagship, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

出版信息

Arthritis Res Ther. 2024 Jul 16;26(1):133. doi: 10.1186/s13075-024-03366-x.

Abstract

BACKGROUND

Most estimates of rheumatoid arthritis (RA) prevalence, including all official figures in Australia and many other countries, are based on self-report. Self-report has been shown to overestimate RA, but the 'gold standard' of reviewing individual medical records is costly, time-consuming and impractical for large-scale research and population monitoring. This study provides an algorithm to estimate RA cases using administrative data that can be adjusted for use in multiple contexts to provide the first approximate RA cohort in Australia that does not rely on self-report.

METHODS

Survey data on self-reported RA and medications from 25 467 respondents of the Australian Longitudinal Study on Women's Health (ALSWH) were linked with data from the national medication reimbursement database, hospital and emergency department (ED) episodes, and Medicare Benefits codes. RA prevalence was calculated for self-reported RA, self-reported RA medications, dispensed RA medications, and hospital/ED RA presentations. Linked data were used to exclude individuals with confounding autoimmune conditions.

RESULTS

Of 25 467 survey respondents, 1367 (5·4%) women self-reported disease. Of the 26 840 women with hospital or ED presentations, 292 (1·1%) received ICD-10 codes for RA. There were 1038 (2·8%) cases by the medication database definition, and 294 cases (1·5%) by the self-reported medication definition. After excluding individuals with other rheumatic conditions, prevalence was 3·9% for self-reported RA, 1·9% based on the medication database definition and 0·5% by self-reported medication definition. This confirms the overestimation of RA based on self-reporting.

CONCLUSIONS

We provide an algorithm for identifying individuals with RA, which could be used for population studies and monitoring RA in Australia and, with adjustments, internationally. Its balance of accuracy and practicality will be useful for health service planning using relatively easily accessible input data.

摘要

背景

大多数类风湿关节炎(RA)患病率的估计,包括澳大利亚和许多其他国家的所有官方数据,都是基于自我报告。研究表明,自我报告往往会高估RA,但审查个人病历这一“金标准”成本高昂、耗时且不适用于大规模研究和人群监测。本研究提供了一种使用行政数据估计RA病例的算法,该算法可针对多种情况进行调整,以提供澳大利亚首个不依赖自我报告的近似RA队列。

方法

澳大利亚妇女健康纵向研究(ALSWH)的25467名受访者关于自我报告的RA和药物治疗的调查数据,与国家药物报销数据库、医院和急诊科(ED)就诊记录以及医疗保险福利代码数据相关联。计算自我报告的RA、自我报告的RA药物、配发的RA药物以及医院/ED的RA就诊情况的患病率。使用关联数据排除患有混淆性自身免疫疾病的个体。

结果

在25467名调查受访者中,1367名(5.4%)女性自我报告患有该疾病。在26840名有医院或ED就诊记录的女性中,292名(1.1%)获得了RA的国际疾病分类第10版(ICD - 10)代码。根据药物数据库定义有1038例(2.8%)病例,根据自我报告的药物定义有294例(1.5%)病例。排除患有其他风湿性疾病的个体后,自我报告的RA患病率为3.9%,基于药物数据库定义为1.9%,根据自我报告的药物定义为0.5%。这证实了基于自我报告对RA的高估。

结论

我们提供了一种识别RA患者的算法,该算法可用于澳大利亚的人群研究和RA监测,并经过调整后可在国际上使用。其准确性和实用性的平衡将有助于利用相对容易获取的输入数据进行卫生服务规划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a232/11251372/35182f55ef3f/13075_2024_3366_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验